Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hair loss in postmenopausal woman caused by ovarian issue.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Deslorelin implants successfully treated hair loss in two male Keeshonden dogs.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Finasteride reduces hair growth and is safe for women with excessive hair.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.